Ledger.Open graph →
SEC Form D · filed May 10, 2016

DelMar Pharmaceuticals, Inc

Offering
—
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John K. Bell · Vancouver, British Columbia, CanadaDirectorRobert K. Toth · Vancouver, British Columbia, CanadaDirectorDennis Brown · Vancouver, British Columbia, CanadaExec · DirectorScott Praill · Vancouver, British Columbia, CanadaExecJeffrey Bacha · Vancouver, British Columbia, CanadaExec · DirectorJohn Elliot · Washington, Washington, D.C.ExecPeter Jun · Washington, Washington, D.C.DirectorWoonki Sung · Washington, Washington, D.C.Exec · DirectorKi Bum Kim · Washington, Washington, D.C.Exec · DirectorLynda Cranston · Vancouver, British Columbia, CanadaDirectorErich K. Mohr · Vancouver, British Columbia, CanadaDirectorPeter Jun · Washington, Washington, D.C.DirectorGary Mottola · Washington, Washington, D.C.Exec · DirectorStage.O Management, LLC · Kirkland, WAExecJuan W. Vallarino · BRENTWOOD, TNExec · DirectorRobert K. Toth · Vancouver, British Columbia, CanadaDirectorLynda Cranston · Vancouver, British Columbia, CanadaDirectorErich K. Mohr · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗